Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Small intestinal bacterial overgrowth syndrome

J. Bures, J. Cyrany, D. Kohoutova, M. Förstl, S. Rejchrt, J. Kvetina, V. Vorisek, M. Kopacova,

. 2010 ; 16 (24) : 2978-90.

Jazyk angličtina Země Tchaj-wan

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025635

Human intestinal microbiota create a complex polymicrobial ecology. This is characterised by its high population density, wide diversity and complexity of interaction. Any dysbalance of this complex intestinal microbiome, both qualitative and quantitative, might have serious health consequence for a macro-organism, including small intestinal bacterial overgrowth syndrome (SIBO). SIBO is defined as an increase in the number and/or alteration in the type of bacteria in the upper gastrointestinal tract. There are several endogenous defence mechanisms for preventing bacterial overgrowth: gastric acid secretion, intestinal motility, intact ileo-caecal valve, immunoglobulins within intestinal secretion and bacteriostatic properties of pancreatic and biliary secretion. Aetiology of SIBO is usually complex, associated with disorders of protective antibacterial mechanisms (e.g. achlorhydria, pancreatic exocrine insufficiency, immunodeficiency syndromes), anatomical abnormalities (e.g. small intestinal obstruction, diverticula, fistulae, surgical blind loop, previous ileo-caecal resections) and/or motility disorders (e.g. scleroderma, autonomic neuropathy in diabetes mellitus, post-radiation enteropathy, small intestinal pseudo-obstruction). In some patients more than one factor may be involved. Symptoms related to SIBO are bloating, diarrhoea, malabsorption, weight loss and malnutrition. The gold standard for diagnosing SIBO is still microbial investigation of jejunal aspirates. Non-invasive hydrogen and methane breath tests are most commonly used for the diagnosis of SIBO using glucose or lactulose. Therapy for SIBO must be complex, addressing all causes, symptoms and complications, and fully individualised. It should include treatment of the underlying disease, nutritional support and cyclical gastro-intestinal selective antibiotics. Prognosis is usually serious, determined mostly by the underlying disease that led to SIBO.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025635
003      
CZ-PrNML
005      
20120918124441.0
007      
ta
008      
120817s2010 ch f 000 0#eng||
009      
AR
024    7_
$a 10.3748/wjg.v16.i24.2978 $2 doi
035    __
$a (PubMed)20572300
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ch
100    1_
$a Bureš, Jan, $d 1954- $7 nlk19990073060 $u 2nd Department of Medicine, Charles University in Praha, Faculty of Medicine at Hradec Kralove, University Teaching Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. bures@lfhk.cuni.cz
245    10
$a Small intestinal bacterial overgrowth syndrome / $c J. Bures, J. Cyrany, D. Kohoutova, M. Förstl, S. Rejchrt, J. Kvetina, V. Vorisek, M. Kopacova,
520    9_
$a Human intestinal microbiota create a complex polymicrobial ecology. This is characterised by its high population density, wide diversity and complexity of interaction. Any dysbalance of this complex intestinal microbiome, both qualitative and quantitative, might have serious health consequence for a macro-organism, including small intestinal bacterial overgrowth syndrome (SIBO). SIBO is defined as an increase in the number and/or alteration in the type of bacteria in the upper gastrointestinal tract. There are several endogenous defence mechanisms for preventing bacterial overgrowth: gastric acid secretion, intestinal motility, intact ileo-caecal valve, immunoglobulins within intestinal secretion and bacteriostatic properties of pancreatic and biliary secretion. Aetiology of SIBO is usually complex, associated with disorders of protective antibacterial mechanisms (e.g. achlorhydria, pancreatic exocrine insufficiency, immunodeficiency syndromes), anatomical abnormalities (e.g. small intestinal obstruction, diverticula, fistulae, surgical blind loop, previous ileo-caecal resections) and/or motility disorders (e.g. scleroderma, autonomic neuropathy in diabetes mellitus, post-radiation enteropathy, small intestinal pseudo-obstruction). In some patients more than one factor may be involved. Symptoms related to SIBO are bloating, diarrhoea, malabsorption, weight loss and malnutrition. The gold standard for diagnosing SIBO is still microbial investigation of jejunal aspirates. Non-invasive hydrogen and methane breath tests are most commonly used for the diagnosis of SIBO using glucose or lactulose. Therapy for SIBO must be complex, addressing all causes, symptoms and complications, and fully individualised. It should include treatment of the underlying disease, nutritional support and cyclical gastro-intestinal selective antibiotics. Prognosis is usually serious, determined mostly by the underlying disease that led to SIBO.
650    _2
$a syndrom slepé kličky $x epidemiologie $x etiologie $x patofyziologie $x terapie $7 D001765
650    _2
$a dechové testy $7 D001944
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a lidé $7 D006801
650    _2
$a tenké střevo $x mikrobiologie $x patologie $7 D007421
650    _2
$a prognóza $7 D011379
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Cyrany, Jiří $7 xx0165194
700    1_
$a Kohoutová, Darina. $7 mzk2013797579
700    1_
$a Förstl, Miroslav, $d 1971-2011 $7 mzk2003192172
700    1_
$a Rejchrt, Stanislav, $d 1963- $7 mzk2005306779
700    1_
$a Květina, Jaroslav
700    1_
$a Vorisek, Viktor
700    1_
$a Kopáčová, Marcela $7 xx0032944
773    0_
$w MED00006918 $t World journal of gastroenterology : WJG $x 1007-9327 $g Roč. 16, č. 24 (2010), s. 2978-90
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20572300 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20120918124622 $b ABA008
999    __
$a ok $b bmc $g 947677 $s 782981
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 16 $c 24 $d 2978-90 $i 1007-9327 $m World journal of gastroenterology $n World J Gastroenterol $x MED00006918
LZP    __
$a Pubmed-20120817/10/03

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...